Form 4 for PTGX Protagonist Therapeutics, Inc
Accepted 2026-02-06 00:00:00 ET · period of report 2026-02-06 · accession 0001104659-26-011575 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-06 | 2026-02-06 | PTGX | Waddill William D. | Dir | M - OptEx | $8.31 | +20.0K | 27.8K | +256% | +$166.2K |
| D | 2026-02-06 | 2026-02-06 | PTGX | Waddill William D. | Dir | S - Sale+OE | $83.68 | -20.0K | 7,825 | -72% | -$1.67M |
| D | 2026-02-06 | 2026-02-06 | PTGX | Waddill William D. | Dir | M - OptEx | $0.00 | -20.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-06 | M | A | 20,000 | $8.31 | 27,825 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-06 | S | D | 20,000 | $83.68 | 7,825 | D | — | — | (F1) The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $83.65 to $83.87. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. |
| 3 | Derivative | Stock Option (right to buy) | 2026-02-06 | M | D | 20,000 | $0.00 | 0 | D | $8.31 · — to 2032-05-25 | 20,000 Common Stock | (F2) These stock options are fully vested. |